Biogen, Inc., headquartered in Cambridge, Mass., announced today that it licensed MT-1303 from Mitsubishi Tanabe Pharma Corporation, located in Osaka, Japan. MT-1303 is being investigated in a number of autoimmune […]
GlaxoSmithKline’s inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of 16,500 people, torpedoing hopes of a sales boost for the […]
Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. […]
An independent non-profit organization that evaluates clinical and cost effectiveness of new medicines said announced prices for a just-approved class of potent cholesterol lowering drugs were far too high, according […]
U.S. Food and Drug Administration staff have expressed concerns over likely errors in administering Purdue Pharma’s fast-acting oxycodone painkiller that could result in inadequate relief. The drug is designed to […]
Roche Chief Executive Severin Schwan criticized Britain’s health system on Tuesday after two of the company’s cancer drugs were dropped from use, calling it a “stupid” way to control costs […]
Canadian company Concordia Healthcare[2] (CXR.TO[3]), headquartered in Oakville, Ontario, announced[4] today that it is buying Amdipharm Mercury Limited[5] (AMCo) from Cinven[6] for $3.5 billion. Cinven is a European private equity […]
An early-stage study shows Bristol-Myers Squibb Co’s Opdivo treatment can be safely and effectively paired with relatively low and infrequent dosages of the company’s other immunotherapy, Yervoy, for patients with […]
Novartis AG said on Friday it received European Union approval for Farydak, a treatment for multiple myeloma that the company said gives new options for adult patients whose disease has […]
Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental hemophilia medicine, aiming for a piece of the $11 billion […]